Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer ; volume:14 ; number:1 ; day:13 ; month:9 ; year:2016 ; pages:1-9 ; date:12.2016
World journal of surgical oncology ; 14, Heft 1 (13.9.2016), 1-9, 12.2016
- Creator
-
Park, Chansub
- Contributor
-
Park, Kyeongmee
Kim, Jiyoung
Sin, Youngjoo
Park, Inseok
Cho, Hyunjin
Yang, Keunho
Bae, Byung Noe
Kim, Ki Whan
Ahn, Sookyung
Gwak, Geumhee
SpringerLink (Online service)
- DOI
-
10.1186/s12957-016-0999-x
- URN
-
urn:nbn:de:1111-20161014732
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Chansub
- Park, Kyeongmee
- Kim, Jiyoung
- Sin, Youngjoo
- Park, Inseok
- Cho, Hyunjin
- Yang, Keunho
- Bae, Byung Noe
- Kim, Ki Whan
- Ahn, Sookyung
- Gwak, Geumhee
- SpringerLink (Online service)
Other Objects (12)
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer